Seaport Therapeutics Inc
NASDAQ:SPTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Seaport Therapeutics Inc
NASDAQ:SPTX
|
US |
|
B
|
BNP Paribas SA
XMUN:BNP
|
FR |
|
Ferrari NV
MIL:RACE
|
IT |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Seaport Therapeutics Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Seaport Therapeutics Does
Seaport Therapeutics, Inc. is a clinical-stage therapeutics company, which engages in the provision of inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company is headquartered in Boston, Massachusetts and currently employs 58 full-time employees. The company went IPO on 2026-05-01. The firm is focused on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders.
- Headquarters
- United States of America US
- Employees
- 58
- IPO date
- May 1, 2026